USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Univax Biologics, Inc.
Address: 12280 Wilkins Avenue
Rockville, MD 20852
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $257,453.00 5

Award List:

THE DEVELOPMENT OF PROTECTIVE MONOCLONAL ANTIBODIES AGAINST TETRODOTOXIN

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency / Branch: DOD / ARMY
Principal Investigator: Dr W Ripley Ballou
Award Amount: $44,125.00
Abstract:
The overall goal of this sbir proposal is the development of human monoclonal antibodies (mabs) that bind to and neutralize tetrodotoxin (ttx), a low molecular weight neurotoxin. in phase i we will prepare a series of ttx conjugate vaccines to prepare murine mabs that bind to various regions of the… More

THE DEVELOPMENT OF HUMAN ANTIBODIES AGAINST RICIN BY INVITOR STIMULATION

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency / Branch: DOD / ARMY
Principal Investigator: Dr D Craig Wright
Award Amount: $64,212.00
Abstract:
This sbir proposal describes the development of an approach to immunoprophylaxis against ricin toxin. we plan to produce a ricin toxoid vaccine for the development of human monoclonal antibodies against ricin toxin. in phase i, we propose to produce and characterie a candidate ricin toxoid vaccine… More

SYNTHETIC CONJUGATE VACCINES AGAINST PLASMODIUM FALCIPARUM

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: HHS
Principal Investigator: D Craig Wright
Award Amount: $49,170.00
Abstract:
The overall goal of this research is the development of a synthetic peptide conjugate vaccine that will elicit neutralizing antibodies against plasmodium falciparum sporozoites. this project is built upon a previously identified murine monoclonal antibody raised againt p. falciparum sporozoites that… More

ANTI-IDIOTYPE VACCINES AGAINST FLAVIVIRUSES

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: HHS
Principal Investigator: Bennett M Kaufman
Award Amount: $49,978.00
Abstract:
The goal of this research is the development of a murine monoclonal anti-idiotype vaccine that will elicit neutralizing antibodies against the flavivirus group of arboviruses, in particular dengue types 1-4. in phase i, mice will be immunized with a previously characterized murine monoclonal… More

DEVELOPMENT OF GROUP B STREPTOCOCCAL CONJUGATE VACCINES

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yanling Zhang
Award Amount: $49,968.00
Abstract:
Group b streptococcal infections are a leading cause of neonatal sepsis. this incidence of invasive infections during the first two months of life is approximately 2-3 cases per 1000 live births. despite advances in diagnosis, supportive care and treament, mortality and morbidity from these… More